Non-substantive Change Request Justification

OD2A_APR_OPCAT_Request Template Non substantial change8.25.21.docx

Monitoring and Reporting for the Overdose Data to Action Cooperative Agreement

Non-substantive Change Request Justification

OMB: 0920-1283

Document [docx]
Download: docx | pdf


Change Request

Monitoring and reporting for the Overdose Data to Action Cooperative Agreement

(OMB no. OMB# 0920-1283 exp. date 1/31/2023)

Proposed Changes: Justification and Overview

August 25, 2021

Justification

In October 2017, HHS declared a public health emergency to address the national opioid crisis. This information collection change request supports improvements to CDC monitoring of response efforts in 66 jurisdictions.

Project Description



The purpose of the Overdose Data to Action (CDC-RFA-CE19-1904) notice of funding opportunity (OD2A NOFO), is to support funded jurisdictions, in getting high quality, complete, and timelier data on opioid prescribing and overdoses, and to use those data to inform prevention and response efforts. CDC will use the information collected to monitor each recipient’s progress and to identify facilitators and barriers to program implementation and achievement of outcomes. OD2A is currently in Year 3. To obtain key information not originally captured, streamline data collection, and minimize burden to recipients, changes are being requested to the following data collection tools:

1) Evaluation and Performance Measuring Plan: Items have been added to capture recipient peer-to-peer activities and more detail within the data collection methods. Items have been moved and, in some cases, removed to streamline the reporting form.

2) Overdose Prevention Capacity Assessment Tool: Items have been added that capture key capacity areas not initially included on the form. This information is pertinent to capacity around health equity, harm reduction, and evaluation. Some language has been edited to reflect more appropriate terms (e.g., disproportionately affected populations).

3) Annual Activity Progress Report and Workplan: Items have been removed from the Annual Activity Progress Report that were duplicative. Also, to improve clarity, several questions have been reworded or had clarifying language added.

These changes are crucial to the success of our program and ability to continue monitoring whether a recipient is meeting performance and budget goals, assess progress with respect to capacity building, and make adjustments in the type and level of technical assistance provided to funded jurisdictions as needed. These functions are central to NCIPC’s broad mission of protecting Americans from violence and injury threats.



Proposed Changes


1) Evaluation and Performance Measuring Plan

Table A. Changes from Existing Evaluation Plan 1.0 to Evaluation Plan 2.0 in Partners Portal

Existing

Change

Indicators field stated “indicators”

We added clarifying fields “indicator name” and “indicator description”

Data collection methods section

Added “data source” field

Under data collection methods, field “frequency of data collection” currently exists

Delete “frequency of data collection”

In the timeline for data collection and analysis, we did not have data reporting

We have moved the timeline field within the new category of data collection and analysis where evaluation data can be reported. New fields include:

  • Reporting year

  • Value (quantitative and qualitative)

  • Year

  • Notes

No peer-to-peer evaluation component currently exists in Partners Portal evaluation plan template

An additional “strategy” that would replicate each field for the peer-to-peer funded jurisdictions to complete.



2) Overdose Prevention Capacity Assessment Tool

Table B. Changes from Existing OPCAT 1.0 to OPCAT 2.0

Existing


Change

Infrastructure Section

No direct mention of health equity

Additions of health equity into key infrastructure areas

  • Under multilevel leadership, added a component on “leadership to incorporate health equity in overdose prevention exists across levels” (p3)

  • Under networked partnerships, added a component, “Shared planning of health equity efforts” (p8)

No evaluation capacity section

Added crucial section on Evaluation Capacity as it is a key component of the NOFO

  • New section on evaluation capacity has components on “evaluation expertise”, “technology for evaluation, data access, management, and analysis”, “staff (internal or contract) capacity to collect, manage, and analyze evaluation data”, “dissemination and use of evaluation findings” (p5-6)

The word opioid was used in the section Responsive Plans and Planning

Under Responsive Plans and Planning, changed opioid to overdose (p 10 and 11)

Under Data to Action, states high risk populations and uses the work stakeholders

Throughout the document, changed the language to align with the CDC health equity guide

  • Changed high risk to disproportionately affected (p12)

  • Changed stakeholders to partners (p14)

Under Managed Resources, stated “your” jurisdiction

Aligned language to the rest of the document to state “my” jurisdiction (p15)

Under Managed Resources, lists types of staff

Added evaluators as a staff type as it was missing (p16)

Topical Capacity Section

Section Conducting Public Health Surveillance, language states high burden

Throughout the document, changed the language to align with the CDC health equity guide

  • Changed to disproportionately affected (p18)




In the scoring of each topic, the last two options stated:

  • Initiatives are developed but are either 1) targeted to the general population and not specifically to those in need or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

  • Have targeted initiatives to those in need (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.


  • Initiatives are developed but are either 1) implemented with the general population and not specifically to priority populations or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

  • Have prioritized initiatives to those disproportionately affected (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.



Changes in the following pages: 22-34, 36


Section name was Highest burden populations identification, assessment of needs, and targeted initiatives to address needs (e.g., AA, NA/AI, Women Reproductive age, Adolescents, Senior Citizens, Chronic Pain Patients)

Section name changed to the following due to changes in health equity language:

Identification of populations who are disproportionately affected by overdose, assessment of needs, and prioritized initiatives to address needs (e.g., AA, NA/AI, Women Reproductive age, Adolescents, Senior Citizens, Chronic Pain Patients) (p33)

No topical section on health equity

Added section in topical capacity to measure health equity in overdose “Incorporating Health Equity into Overdose Efforts (e.g., implementing health equity initiatives, utilization of health equity indicators, leveraging partnerships to address health equity)” (p35)

No topical section on harm reduction

Added section in topical capacity to measure harm reduction efforts, “Harm reduction initiatives (e.g., support of syringe service programs, safer injection education programs, outreach to people who use drugs)” (p37)



3) Annual Activity Progress Report and Workplan:

Table C. Changes from Existing Annual Progress Report 1.0 to Annual Progress Report 2.0 in Partners Portal

 

Original question from APR 

Change Needed 

Revised question, if applicable 

Any additional comments? 

 

Summary Level

 

 

 

Briefly describe how your jurisdiction plans to sustain programmatic successes and how facilitators impacted your successes. 

 

 

Briefly describe progress to date on this strategy and what factors have facilitated your progress. (e.g., existing/strong partnerships, policies, champion for initiative, etc) 

What aspects facilitated your success? 

Briefly describe how your jurisdiction overcame programmatic challenges/barriers (e.g., budgetary, political, etc.).  

 

 

Briefly describe how your jurisdiction overcame programmatic challenges/barriers implementing this strategy (e.g., budgetary, political) 

 

Describe what CDC can do to help further address challenges your jurisdiction is experiencing. 

Omit question since it is answered under TA Needs (under each activity) 

 

Make sure to capture contextual progress elsewhere (include instructions in the barriers section) 

How effective were the administrative and assessment processes to ensuring successful implementation and quality assurance? 

 

Omit question since this information is already captured in the workplan 

 

 

What are examples of how lessons learned were translated and disseminated? 

Change wording of the question 

Provide examples of how the findings of the activity were disseminated. 

What  if any, lessons were learned implementing this activity? Describe implementation lessons learned here (e.g., information others might want to know when implementing a similar activity in their jurisdiction) 

Was information from this activity disseminated into products? Were resources developed, papers 

What are some lessons learned (at the strategy level) and what are you going to do with these lessons that you learned? What are some lessons learned and what are some changes that you plan to make based on the lessons learned 

 

 

 

 

 

 

Objectives 

Pre-populated from the workplan 

 

 

14 

Describe your progress to date for this objective 

Omit question, information is captured for each activity 

 

 

15 

How did you address barriers to reaching this objective? 

Omit question, duplicative 

 

Option 1: Potentially keep this question and delete at the summary level 

16 

How effective were the facilitators you used to help reach this objective? 

Omit question, information is captured for each activity 

 

Option 2: Roll this question up to the summary level to streamline 

 

ACTIVITY 

Pre-populated from the workplan 

 

 

20 

Activity: Describe your progress to date for this activity 

 

 

Include successes here; include where is the activity to date 

21 

Successes 

Delete question; this can be rolled up into the progress to date question. Successes are oftentimes discussed in that question 

 

Ok to omit 

22 

Challenges 

 

 

 

23 

What steps were taken to engage each target population? 

 

 

 

24 

What was the role of staff and administration in supporting this activity? 

Duplicative question, omit; this information is already captured in the workplan 

 

Ok to omit 

25 

Report progress on the output, if applicable. 

All activities should have an output 

Report progress on the output. Including additional outputs that may have been generated by this activity. 

In the instructions provide concrete examples; include translation and dissemination 

26 

Do you need Technical Assistance? 

 

 

Remove 

27 

TA Need 

 

 

Describe what CDC can do to help you with your activity? 

 

 

 

Legend 

 

 

Omit question from APR 

Orange 

 

 

 



Change to Burden and/or Cost

The proposed templates do not collect sensitive information. In addition, these changes are non-substantive and do not include changes to the currently approved burden and/or costs.”

Current approved burden and cost associated with the collection of data:

Estimates of Annualized Burden Hours and Costs

Annual Burden Hours

Respondents will be the 66 funded jurisdictions of the Overdose Data to Action funding opportunity. Respondents are starting Year 3 of funding. Annually, funded jurisdictions will report: 1) activity progress and work plan information using a the Partner’s Portal (attachment 3c); 2) evaluation and performance measurement plan using the Partner’s Portal (attachment 3a); and 3) organizational capacity using a web-based assessment tool (attachment 3b). The estimate burden for each instrument includes time for reviewing instructions, searching sources, data collection, and completion of the templates.

The evaluation and performance measurement plan template (Attachment 3a) has an estimated burden per response of 12 hours for the initial submission and 4 hours for subsequent submissions. The burden is based on feedback from jurisdictions funded by a previous funding opportunity that used a similar template to plan their evaluation and performance measurement opportunities (OMB# 0920-1155 - Monitoring and reporting systems for the prescription drug overdose prevention for states coop agreement). The operational capacity assessment (Attachment 3b) is web-based tool. Based on pilot testing using 9 staff members from the Association of State and Territorial Health Officials, the estimated burden per response is 1 hour for the initial submission and 1 hour for subsequent submissions.

The annual activity progress report and work plan (Attachment 3c) is web-based tool. The estimated burden per response is 20 hours for the initial submission and 4 hours for subsequent submissions. The burden is based on feedback from jurisdictions funded by a previous funding opportunity that used a similar progress report which was modified for this funding opportunity opportunities (OMB# 0920-1155 - Monitoring and reporting systems for the prescription drug overdose prevention for states coop agreement). The surveillance data dissemination plan (attachment 3d) is a web-based tool. The estimated burden per response is 1 hour for the one-time submission. The burden is based on feedback from jurisdictions funded by a previous funding opportunity that used a similar template which was modified for this funding opportunity.

The total estimated annual burden for all funded jurisdictions is summarized in Table A.

Table D. Estimated Annualized Burden Hours

Type of respondents

Form Name

Number of respondents

Number of responses per respondent


Average burden per response (in hours)

Total burden (in hours)



Overdose Data to Action funded jurisdictions (State, territories, counties and cities)  and their Designated Delegates

Evaluation and Performance Measuring Plan Template – Initial Population (Att. 3a)



22



1



12



264

Evaluation and Performance Measuring Plan Template - Annual reporting (Att. 3a)

66

1

4

264

Organizational Capacity Assessment - Initial Population (attachment 3b)

22

1

1

22

Organizational Capacity Assessment - Annual Reporting (attachment 3b)

66

1

1

66

Activity Progress Report and Work Plan Tool – Initial Population (Att. 3c)

22

1

20

440

Activity Progress Report and Work Plan Tool – Annual Reporting (Att. 3c)

66

1

4

264

Surveillance Data Dissemination Plan Tool (attachment 3d)

22

1

1

22

Total

1,342



Annual Burden Costs


Respondents will be health department program staff or designated delegate, who are program managers or several types of staff. Program manager salaries vary widely based on actual title and institution. The average hourly wage for a program manager is $32.35 according to the 2018 National Occupational Employment and Wage Estimates from the U.S. Bureau of Labor Statistics. The salary of an evaluator also varies based on title and institution. The average hourly wage for an evaluator is $33.34. The total estimated cost over four years annualized is $68,213.64 as summarized in Table B.

Table E. Estimated Annualized Burden Costs

Type of respondents

Form Name

Total Burden Hours

Average Hourly Wage Rate (in dollars)





Total Costs

Overdose Data to Action funded jurisdictions (State, territories, counties and cities)  and their Designated Delegates

Initial Evaluation and Performance Measuring Plan Template

264



$33.34

$8,802

Annual Evaluation and Performance Measuring Plan Template

264

$33.34

$8,802

Initial Organizational Capacity Assessment

22



$33.34

$734

Annual Organizational Capacity Assessment

66





$33.34

$2,200

Initial Activity Progress Report and Work Plan Tool

440



$33.34

$14,670

Annual Activity Progress Report and Work Plan Tool

264



$33.34

$8,802

Surveillance Data Dissemination Plan Template

22

$33.34

$735

Total: $ 45,479





A.13. Estimates of Other Total Annual Cost Burden to Respondents or Record Keepers



No capital or maintenance costs are expected. Additionally, there are no start-up, hardware, or software costs.

Annualized Cost to the Government

The average annualized cost to the federal government is $1,939,659.

Table F. Estimated Annualized Cost to the Government

Type of Cost

Description of Services

Annual Cost

CDC Personnel


  • 100% GS-12@$71,901/year = $71,901

  • 50% GS-13 @ $85,500/year = $42,500

  • 25% GS-14 @ $101,035/year = 25,258

Subtotal, CDC Personnel

$139,659

Contractor

Contractor

$1,800,000

Total Annual Estimated Costs

$1,939,659












Created: 7 December 2009

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleChange Request Guidance
Authorjahlani akil
File Modified0000-00-00
File Created2021-09-15

© 2024 OMB.report | Privacy Policy